Adipose tissue gene expression and metabolic health of obese adults

International Journal of Obesity

Volumn 39, Issue 5, 2015, Pages 869-873

  Das, S K ^a   Ma, L ^a   Sharma, N K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOPONTIN; GINS3 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; MUSCLE PROTEIN; NDRG4 PROTEIN, HUMAN; NERVE PROTEIN; NONHISTONE PROTEIN;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DOWN REGULATION; FAT MASS; FEMALE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC TRANSCRIPTION; GINS3 GENE; HEART REPOLARIZATION; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID HOMEOSTASIS; MALE; METABOLIC REGULATION; MULTIGENE FAMILY; NDRG4 GENE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TRANSCRIPTOMICS; UPREGULATION; ANIMAL; CARDIOVASCULAR DISEASES; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PHENOTYPE; ZEBRA FISH;

DANIO RERIO;

ADIPOSE TISSUE; ADULT; ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHROMOSOMAL PROTEINS, NON-HISTONE; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; OBESITY; PHENOTYPE; ZEBRAFISH;

EID: 84928925693     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.210     Document Type: Article

References (20)

1. Ahima RS, Lazar MA. Physiology. The health risk of obesity-better metrics imperative. Science 2013; 341: 856-858.
2. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 38-43.
3. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013; 14: 219-227.
4. Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen MD et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 2013; 17: 644-656.
5. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 2009; 5: e1000324.
6. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
7. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
8. Das SK, Sharma NK, Hasstedt SJ, Mondal AK, Ma L, Langberg KA et al. An integrative genomics approach identifies activation of thioredoxin/thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects. J Clin Endocrinol Metab 2011; 96: E1308-E1313.
9. Elbein SC, Kern PA, Rasouli N, Yao-Borengasser A, Sharma NK, Das SK. Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI. Diabetes 2011; 60: 1019-1029.
10. Keller MP, Attie AD. Physiological insights gained from gene expression analysis in obesity and diabetes. Annu Rev Nutr 2010; 30: 341-364.
11. Qatanani M, Tan Y, Dobrin R, Greenawalt DM, Hu G, Zhao W et al. Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients. Diabetes 2013; 62: 855-863.
12. Sharma NK, Langberg KA, Mondal AK, Das SK. Phospholipid biosynthesis genes and susceptibility to obesity: analysis of expression and polymorphisms. PLoS One 2013; 8: e65303.
13. Caraux G, Pinloche S. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 2005; 21: 1280-1281.
14. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
15. Huang dW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
16. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377.
17. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 2009; 41: 399-406.
18. Pfeufer A, Sanna S, Arking D. E, Muller M, Gateva V, Fuchsberger C et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 2009; 41: 407-414.
19. Qu X, Jia H, Garrity DM, Tompkins K, Batts L, Appel B et al. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 2008; 317: 486-496.
20. Milan DJ, Kim AM, Winterfield JR, Jones IL, Pfeufer A, Sanna S et al. Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 2009; 120: 553-559.